<DOC>
	<DOCNO>NCT02153372</DOCNO>
	<brief_summary>In present phase-I clinical trial investigate safety feasibility augmentation preoperatively isolate autologous BMC cell seed onto ß-TCP combination angle stable fixation ( Philos plate® ) therapy proximal humeral fracture .</brief_summary>
	<brief_title>Cell Therapy Bone Marrow-derived Mononuclear Cells ( BMC ) Large Bone Defect Repair : Phase-I Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Humeral Fractures</mesh_term>
	<criteria>patient age 50. 90. year proximal humerus fracture indication open reposition internal stabilisation proximal fix angle plate humerus ( PHILOS , Synthes , Oberdorf , Swiss ) : 2 , 3 4fragment fracture accord NEer dislocation &gt; 10 mm fragment and/or angle &gt; 45° fragment and/or dislocation tuberculum major &gt; 5 mm negative pregnancy test premenopausal woman sign informed consent surgery participation clinical trial contraindication administration Investigational medicinal product ( IMP ) pregnancy nurse dislocation fracture know psychic disorder lead incompliance ( e.g . dementia , schizophrenia , major depression ) pathologic fracture cause underlying disease fractureinduced nerve damage tumor disease recent adjuvant therapy treatment last 3 month ( e.g . chemotherapy , radiotherapy ) , untreated tumor disease know hypersensibility component transplant participation clinical trial last 3 month prior study</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>large bone defect , bone marrow-derived mononuclear cell</keyword>
</DOC>